Skip to content
The Kids Research Institute Australia logo
Donate

Discover . Prevent . Cure .

Reports and Findings

Research

World Allergy Organization-McMaster University Guidelines for Allergic Disease Prevention (GLAD-P): Prebiotics

Develop evidence-based recommendations about the use of prebiotics in the prevention of allergy

Research

Factors Associated with Respiratory Illness in Children and Young Adults with Cerebral Palsy

Oromotor dysfunction is strongly associated with respiratory illness in patients with cerebral palsy

Research

Systematic chemical and molecular profiling of MLL-rearranged infant acute lymphoblastic leukemia reveals efficacy of romidepsin

Present a valuable resource for drug discovery and have identified ROM as a promising therapeutic for MLL-rearranged iALL

Research

Epigenetic modifications: Mechanisms of disease and biomarkers of food allergy

The rise in IgE-mediated food allergy in recent times is the likely result of gene-environment interactions mediated via epigenetic pathways.

Research

Soft neurological signs and prenatal alcohol exposure: A population-based study in remote Australia

Soft neurological signs were more common in children with prenatal alcohol exposure or FASD, consistent with the known neurotoxic effect of PAE

Research

Rhinovirus-induced asthma exacerbations and risk populations

Asthma exacerbations are heterogeneous conditions that involve the complex interplay between environmental exposures and innate and adaptive immune function

Research

How well can poor child development be predicted from early life characteristics? A whole-of-population data linkage study

A targeted program would have the potential to prevent one-quarter of the cases of being vulnerable on two or more AEDC domains at age five

Research

Interobserver reliability of the Australian Spasticity Assessment Scale (ASAS)

The Australian Spasticity Assessment Scale complies with the definition of spasticity and is clinically feasible in paediatric settings

Research

Human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine for the prevention of cervical cancer and HPV-related diseases

HPV-16/18 AS04-adjuvanted vaccine reduces HPV-16/18 infection and associated cervical endpoints in women regardless of age, location, or sexual experience